Wearable Sensors and Digital Platforms in Health

The JRC project on Trust in Digital Interactions (TRUDI) deals with the construction and renewal of confident and trusted relationships among institutions, corporations and citizens, addressed as a major and urgent issue to be solved. The present report examines relationships for nurturing trust between corporations and citizens. In this context the JRC investigated wearable sensors and digital platforms in health as an empirical case study of citizens' involvement in designing the values embedded in information systems and services as well as their implementation and management.

Personal wearable sensors could become the most powerful individual self-surveillance technology available to citizens. These ubiquitous, networked devices currently offer a breadth of capabilities to sense, digitally enhance and upload data of fine granularity such as body and health physiological functions, images, locations, sounds and motion. However, for wider adoption, it is crucial for citizens/end-users to rely on trusted and trustworthy implementations of wearable sensing technologies. Trusted systems are defined as systems functioning normally and delivering what it is promised and what the user expects, whereas trustworthiness is mostly objectively defined according to specific criteria and can be considered a metric for how much a system deserve the trust of its users (Kounelis et al. 2014). Therefore, in order to establish criteria for trust and trustworthiness, the present report aims to screen and analyse emerging solutions and architectures for verifying how these systems actually work; particularly, for checking whether functionalities, motivations and values embedded in their design hold the potential for user empowerment, equitable use and meaningful community participation in digital health platforms.

Download: Wearable Sensors and Digital Platforms in Health (.pdf, 11.223 KB).

Download from eHealthNews.eu: Wearable Sensors and Digital Platforms in Health (.pdf, 11.223 KB).

Most Popular Now

Philips Launches HealthSuite Clinical Tr…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced Clinical Trial Accelerator on Philips HealthSuite. This new tailored set of capabilities allows life science organizations to...

New AI Diagnostic can Predict COVID-19 w…

Researchers at King's College London, Massachusetts General Hospital and health science company ZOE have developed an artificial intelligence diagnostic that can predict whether someone is likely to have COVID-19 based...

Biomax Provides AI-Based Semantic Search…

The bioinformatics company Biomax, headquartered in Planegg, Germany, makesitssemantic search platform AILANI available free of charge to research institutes around the world in order to support the rapid and successful...

First Virtual DMEA to Open with a Wide R…

16 - 18 June 2020, Berlin, Germany. Under the heading 'DMEA sparks' and taking place for the first time, this year's DMEA is an entirely virtual event. From 16 to 18...

COVID-19 and Health Tech: Building on th…

Highland Marketing's advisory board met to discuss the health tech response to the coronavirus outbreak. In many areas, this has been hugely impressive: but there are gaps, and there will...

InsurTech Hub Munich and dmac/Digital He…

InsurTech Hub Munich (ITHM) and dmac - Medical Valley Digital Health Application Center part of the Digital Health Hub Nuremberg/Erlangen announce a new cross-industry accelerator for the second half of...

Viveo Health Offers Free Telemedicine So…

Viveo Health, a global e-Health innovator, is making its 'Virtual Office for Doctors' platform free of charge to doctors and other medical professionals worldwide in light of the surge in...

The Dedalus Group, Participated by Ardia…

The Dedalus Group, a leading European company, and one of the worldwide main ones, active in clinical healthcare information systems to support clinical professionals and organizations in order to improve...

Supercomputer Simulations Present Potent…

Several drugs approved for treating hepatitis C viral infection were identified as potential candidates against COVID-19, a new disease caused by the SARS-CoV-2 coronavirus. This is the result of research...

The COVID-19 pandemic reveals the potent…

Two new articles provide insights on the use of telehealth or virtual care in the age of COVID-19 and beyond, pointing to its value to not only prevent contagious diseases...

WiFi SPARK Works with Visionable to Conn…

Seven NHS Trusts are using technology developed by WiFi SPARK in response to an urgent request from leading NHS Trusts to find a way to connect hospital patients with their...

Digital Contact Tracing for COVID-19: An…

An article in CMAJ (Canadian Medical Association Journal) analyzes the strengths and limitations of digital contact tracing for people infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to help...